GLI1 and breast neoplasm: These data are consistent with the observation that EMT-TFs converge on Hh/GLI pathway activation independent of Hh ligands and suggest that targeting Hh signalling through downstream effectors such as GLI may be more efficacious in breast tumours expressing EMT-TFs.